Clinical trial

Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in…

NCT00159133 · Heinrich-Heine University, Duesseldorf, Other · Completed

Key facts

NCT number NCT00159133
Title Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia
Official title Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepine in Patients With First-Episode Schizophrenia After One Year Maintenance Treatment Under Further Maintenance Treatment vs. Stepwise Discontinued Drugs
Lead sponsor Heinrich-Heine University, Duesseldorf, Other
Collaborators German Federal Ministry of Education and Research German Research Network On Schizophrenia Janssen-Cilag Ltd. Industry University of Bonn Humboldt-Universität zu Berlin Ludwig-Maximilians - University…
Status Completed
Phase Phase 4
Study type Interventional
Conditions Schizophrenia, Psychoses
Intervention type Drug
Interventions antipsychotics vs. Lorazepam (Drugs)
Enrollment 71
Start date Nov 1, 2001
Primary completion Jun 1, 2006
Completion Jun 1, 2006
First posted Sep 12, 2005
Last update posted Jan 30, 2008
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies